Literature DB >> 20481406

Compounding problems and compounding confusion: federal regulation of compounded drug products and the FDAMA circuit split.

Jesse M Boodoo1.   

Abstract

Mesh：

Year:  2010        PMID： 20481406

Source DB:  PubMed          Journal:  Am J Law Med        ISSN： 0098-8588


× No keyword cloud information.
  4 in total

1.  Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection.

Authors:  John L Chollet; Michael J Jozwiakowski
Journal:  Drug Dev Ind Pharm       Date:  2012-02-13       Impact factor: 3.225

Review 2.  Potential risks of pharmacy compounding.

Authors:  Jennifer Gudeman; Michael Jozwiakowski; John Chollet; Michael Randell
Journal:  Drugs R D       Date:  2013-03

3.  Pharmacy compounding primer for physicians: prescriber beware.

Authors:  Sarah Sellers; Wulf H Utian
Journal:  Drugs       Date:  2012-11-12       Impact factor: 9.546

Review 4.  Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors.

Authors:  C James Watson; James D Whitledge; Alicia M Siani; Michele M Burns
Journal:  J Med Toxicol       Date:  2020-11-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.